Now, the growing buzz around the use of GLP-1 medications like Ozempic to treat alcohol use disorder finally has new clinical ...
The Alabama Poison Information Center has seen a major increase in calls relating to GLP-1 medications. Ozempic, Mounjaro, ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
In the GLP-1 weight loss market, it's largely been a two-horse race between Eli Lilly and Novo Nordisk (NYSE: NVO). The two ...
Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.
16h
ZME Science on MSNOzempic Users Are Drinking Less Alcohol Without Even TryingIn a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...
Promising new research suggests GLP-1 medications like Ozempic and Wegovy may reduce alcohol cravings and consumption in ...
A new study published in the journal JAMA Psychiatry found that semaglutide (sold under brand names like Ozempic and Wegovy) can help curb alcohol cravings. But the limitations of the study, such as ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results